 |
pyridoxal-5’ phosphate monohydrate (P5P) |
|---|---|
| Trade Name | |
| Orphan Indication | Seizures associated with pyridox(am)ine 5'-phosphate oxidase (PNPO) deficiency |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-04 00:00:00 |
| Sponsor | Medicure International Inc.;2-1250 Waverley Street;Winnipeg, Manitoba |
